Director, Commercial Insights and Analytics

Olema Oncology•Boston, MA

1d•$230,000 - $250,000•Hybrid

About The Position

Olema Oncology is seeking a Director, Commercial Insights and Analytics to build and lead an integrated insights capability supporting commercial strategy, launch readiness, and lifecycle planning. The role reports to the SVP, Commercial Strategy and Operations. The Director of Insights and Analytics will serve as a strategic thought partner to Commercial leadership and cross-functional stakeholders, bringing together primary market research, forecasting, and competitive intelligence, to address Olema’s most important business questions. This individual will develop a deep understanding of customers, patients, and competitors, and translate that understanding into clear implications and recommendations for the business. The role will be responsible for ensuring that Olema has the right insights at the right time to inform decisions ranging from product strategy and launch planning to customer engagement, market development, and investment prioritization. This is a highly visible, hands-on role for a leader who is comfortable framing ambiguous business questions, designing research and analytical approaches, pressure-testing assumptions, and translating disparate information into executive-ready recommendations. This role will be based out of either our San Francisco or Boston offices and will require approximately 20% travel.

Requirements

Bachelor’s degree required; MBA, PhD, or another relevant advanced degree preferred.
Strong understanding of biopharmaceutical commercialization in oncology markets, including patient journeys, customer behavior, treatment dynamics, market access, and launch performance.
Deep expertise in analytical methodologies sufficient to frame business questions, interpret outputs, challenge assumptions, and partner effectively with technical and analytical colleagues.
10+ years of progressive responsibility in biopharmaceutical market research, insights, forecasting, competitive intelligence, commercial strategy, management consulting, or related disciplines.
Forward-looking approach to insights generation, including the use of AI-enabled tools, automation, and other modern research methodologies to increase the speed, scale, and quality of market research and strategic insights.
Track record of successfully supporting late-stage assets, launch planning, and in-market brands.
Strong capability in patient-based commercial forecasting, scenario analysis, and market assessment.
Proven ability to integrate primary research, competitive intelligence, secondary analyses, epidemiology, and other evidence into a coherent strategic perspective.
Effective at presenting recommendations and influencing decisions with senior executives and cross-functional leadership teams.
Successful management of agencies, consultants, and other external partners.
Strategic synthesizer: Connects disparate information and identifies the insights that matter most to a business decision.
Structured problem solver: Frames ambiguous questions into clear hypotheses, workstreams, and decision pathways and brings a consulting-style rigor to problem solving.
Collaborative: Works effectively across disciplines and develops strong partnerships across Commercial, Analytics, Data Science, Market Access, Medical Affairs, Clinical Development, Finance, and other functions.
Comfortable with ambiguity: Thrives in a fast-moving environment where information is incomplete and priorities evolve.
High integrity: Brings rigor, objectivity, sound judgment, and appropriate challenge to strategic decision-making.

Responsibilities

Serve as the lead insights thought partner to Commercial leadership, identifying the critical questions, risks, and opportunities that should inform strategy and execution.
Lead an integrated insights planning process and synthesize primary research, secondary data, competitive intelligence, epidemiology, and market developments into a cohesive market perspective.
Translate insights into clear implications and recommendations, identifying priority knowledge gaps and the appropriate approach to address them.
Own the primary market research strategy and annual research plan supporting Olema’s portfolio and commercialization priorities.
Design and execute qualitative and quantitative research to generate insights into unmet needs, treatment decisions, product perceptions, adoption barriers, and market opportunities.
Lead the development, refinement, and governance of patient-based commercial forecasts for Olema’s late-stage portfolio, incorporating epidemiology, patient flow, market research, competitive dynamics, access assumptions, analogs, and clinical and regulatory events.
Develop and communicate scenario-based forecasts to support long-range planning, portfolio prioritization, lifecycle strategy, and business development assessments.
Lead commercial competitive intelligence for Olema’s priority disease areas, maintaining an integrated view of competitors, emerging mechanisms, and evolving treatment paradigms.
Lead synthesis around major congresses, data readouts, regulatory events, and other high-impact milestones.
Define the strategic measurement framework for launch, including KPIs and leading indicators spanning patient dynamics, customer engagement, access, adoption, and market evolution.
Partner with analytical colleagues to ensure required data, reporting, and measurement capabilities are in place.
Lead interpretation of launch performance, integrating quantitative signals with primary research, field insights, and competitive context to identify drivers and recommended actions.